Nuveen
OLMA icon

Nuveen’s Olema Pharmaceuticals OLMA Stock Holding History

Nuveen’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Sell
161,090
-117,900
-42% -$1.58M ﹤0.01% 2568
2026
Q1 		$4.16M Buy
278,990
+49,521
+22% +$1.1M ﹤0.01% 1959
2025
Q4 		$5.74M Buy
229,469
+101,249
+79% +$1.8M ﹤0.01% 1847
2025
Q3 		$1.26M Hold
128,220
– – ﹤0.01% 2514
2025
Q2 		$546K Sell
128,220
-216,076
-63% -$963K ﹤0.01% 2861
2025
Q1 		$1.29M Buy
344,296
+225,862
+191% +$1.14M ﹤0.01% 2518
2024
Q4 		$690K Hold
118,434
– – ﹤0.01% 2865
2024
Q3 		$1.41M Hold
118,434
– – ﹤0.01% 2596
2024
Q2 		$1.28M Buy
118,434
+17,545
+17% +$190K ﹤0.01% 2605
2024
Q1 		$1.14M Hold
100,889
– – ﹤0.01% 2643
2023
Q4 		$1.42M Buy
100,889
+394
+0.4% +$5.29K ﹤0.01% 2573
2023
Q3 		$1.24M Buy
100,495
+45
+0% +$459 ﹤0.01% 2485
2023
Q2 		$907K Buy
+100,450
New +$606K ﹤0.01% 2702
2022
Q2 		– Sell
-437,425
Closed -$2.13M – 3421
2022
Q1 		$2.13M Buy
437,425
+147,982
+51% +$815K ﹤0.01% 2475
2021
Q4 		$2.52M Sell
289,443
-8,059
-3% -$167K ﹤0.01% 2456
2021
Q3 		$8.15M Buy
297,502
+249,727
+523% +$6.74M ﹤0.01% 1919
2021
Q2 		$1.34M Buy
47,775
+3,579
+8% +$102K ﹤0.01% 2888
2021
Q1 		$1.47M Buy
+44,196
New +$1.89M ﹤0.01% 2752

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Nuveen's OLMA Position: Q2 2026 in Review

Nuveen reduced its Olema Pharmaceuticals (OLMA) stake by 42% in Q2 2026, selling an estimated $1.58M and leaving 161,090 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

Nuveen first reported a position in OLMA in Q1 2021 and has held it in 18 quarters since. The position peaked at $8.15M in Q3 2021. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Nuveen held 161,090 shares of Olema Pharmaceuticals worth $2.02M as of Q2 2026.
  • Nuveen sold 117,900 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.58M.
  • Olema Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2568 holding.
  • Nuveen first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
  • Nuveen's Olema Pharmaceuticals position peaked at $8.15M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.